AMRX logo

Amneal Pharmaceuticals, Inc. (AMRX) Operating Profit

Annual Operating Profit:

$353.29M+$90.25M(+34.31%)
December 31, 2024

Summary

  • As of today, AMRX annual operating income is $353.29 million, with the most recent change of +$90.25 million (+34.31%) on December 31, 2024.
  • During the last 3 years, AMRX annual operating profit has risen by +$128.97 million (+57.50%).
  • AMRX annual operating profit is now -11.61% below its all-time high of $399.71 million, reached on December 1, 2010.

Performance

AMRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Quarterly Operating Profit:

$114.02M+$16.46M(+16.87%)
June 30, 2025

Summary

  • As of today, AMRX quarterly operating income is $114.02 million, with the most recent change of +$16.46 million (+16.87%) on June 30, 2025.
  • Over the past year, AMRX quarterly operating profit has increased by +$16.59 million (+17.03%).
  • AMRX quarterly operating profit is now -46.46% below its all-time high of $212.96 million, reached on March 1, 2010.

Performance

AMRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM Operating Profit:

$381.28M+$16.59M(+4.55%)
June 30, 2025

Summary

  • As of today, AMRX TTM operating income is $381.28 million, with the most recent change of +$16.59 million (+4.55%) on June 30, 2025.
  • Over the past year, AMRX TTM operating profit has increased by +$48.69 million (+14.64%).
  • AMRX TTM operating profit is now -15.49% below its all-time high of $451.19 million, reached on September 1, 2010.

Performance

AMRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

AMRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+34.3%+17.0%+14.6%
3Y3 Years+57.5%+103.3%+115.0%
5Y5 Years+10000.0%+517.0%+195.1%

AMRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+76.3%at high+204.9%at high+133.8%
5Y5-Yearat high>+9999.0%at high+393.4%at high+195.1%
All-TimeAll-Time-11.6%+1485.8%-46.5%+801.5%-15.5%+1595.5%

AMRX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$114.02M(+16.9%)
$381.28M(+4.5%)
Mar 2025
-
$97.56M(+22.1%)
$364.68M(+3.2%)
Dec 2024
$353.29M(+34.3%)
$79.92M(-11.0%)
$353.29M(+2.6%)
Sep 2024
-
$89.77M(-7.9%)
$344.20M(+3.5%)
Jun 2024
-
$97.43M(+13.1%)
$332.59M(+6.7%)
Mar 2024
-
$86.17M(+21.6%)
$311.81M(+18.5%)
Dec 2023
$263.04M(+31.2%)
$70.84M(-9.4%)
$263.04M(-2.7%)
Sep 2023
-
$78.15M(+2.0%)
$270.31M(+14.2%)
Jun 2023
-
$76.65M(+105.0%)
$236.76M(+9.5%)
Mar 2023
-
$37.40M(-52.1%)
$216.19M(+7.1%)
Dec 2022
$200.43M(-10.6%)
$78.11M(+75.1%)
$201.90M(+23.8%)
Sep 2022
-
$44.60M(-20.5%)
$163.09M(-8.0%)
Jun 2022
-
$56.08M(+142.7%)
$177.37M(-8.9%)
Mar 2022
-
$23.11M(-41.2%)
$194.77M(-13.2%)
Dec 2021
$224.31M(+43.5%)
$39.31M(-33.2%)
$224.31M(+4.9%)
Sep 2021
-
$58.88M(-19.9%)
$213.93M(+10.6%)
Jun 2021
-
$73.48M(+39.5%)
$193.37M(+39.7%)
Mar 2021
-
$52.65M(+82.0%)
$138.37M(-11.5%)
Dec 2020
$156.31M(>+9900.0%)
$28.93M(-24.5%)
$156.31M(+21.0%)
Sep 2020
-
$38.31M(+107.3%)
$129.21M(+29.8%)
Jun 2020
-
$18.48M(-73.8%)
$99.55M(+34.5%)
Mar 2020
-
$70.60M(+3777.0%)
$74.03M(+4796.1%)
Dec 2019
$1.51M(-99.5%)
$1.82M(-78.9%)
$1.51M(-97.6%)
Sep 2019
-
$8.64M(+222.9%)
$63.42M(-55.4%)
Jun 2019
-
-$7.04M(-267.0%)
$142.30M(-36.6%)
Mar 2019
-
-$1.92M(-103.0%)
$224.30M(-25.6%)
Dec 2018
$300.78M(+22.4%)
$63.73M(-27.2%)
$301.48M(-5.4%)
Sep 2018
-
$87.53M(+16.8%)
$318.71M(+7.2%)
Jun 2018
-
$74.96M(-0.4%)
$297.43M(+9.3%)
Mar 2018
-
$75.27M(-7.0%)
$272.08M(+38.2%)
Dec 2017
$245.71M(+444.6%)
$80.96M(+22.2%)
$196.82M(+71.4%)
Sep 2017
-
$66.25M(+33.5%)
$114.85M(+43.6%)
Jun 2017
-
$49.61M(>+9900.0%)
$79.98M(+109.4%)
Mar 2017
-
$0.00(+100.0%)
$38.20M(+23.9%)
Dec 2016
$45.12M(-48.4%)
-
-
Dec 2016
-
-$1.01M(-103.2%)
$30.83M(-51.4%)
Sep 2016
-
$31.38M(+300.8%)
$63.41M(-3.1%)
Jun 2016
-
$7.83M(+206.2%)
$65.43M(-15.2%)
Mar 2016
-
-$7.37M(-123.4%)
$77.15M(-12.0%)
Dec 2015
$87.44M(-9.9%)
$31.57M(-5.5%)
$87.64M(+52.3%)
Sep 2015
-
$33.41M(+70.9%)
$57.55M(+13.5%)
Jun 2015
-
$19.55M(+528.1%)
$50.71M(-41.6%)
Mar 2015
-
$3.11M(+110.1%)
$86.86M(-10.5%)
Dec 2014
$97.05M(+301.7%)
$1.48M(-94.4%)
$97.06M(+17.2%)
Sep 2014
-
$26.57M(-52.3%)
$82.81M(+12.3%)
Jun 2014
-
$55.70M(+318.7%)
$73.74M(+162.3%)
Mar 2014
-
$13.30M(+204.2%)
$28.11M(+20.4%)
Dec 2013
$24.16M(-74.0%)
-$12.77M(-172.9%)
$23.36M(-47.2%)
Sep 2013
-
$17.50M(+73.8%)
$44.21M(-20.8%)
Jun 2013
-
$10.07M(+17.8%)
$55.80M(-29.2%)
Mar 2013
-
$8.55M(+5.7%)
$78.81M(-11.5%)
Dec 2012
$92.76M
$8.09M(-72.2%)
$89.04M(-24.5%)
Sep 2012
-
$29.09M(-12.1%)
$117.89M(+1.4%)
DateAnnualQuarterlyTTM
Jun 2012
-
$33.08M(+76.1%)
$116.30M(+12.4%)
Mar 2012
-
$18.78M(-49.2%)
$103.43M(-3.4%)
Dec 2011
$107.12M(-73.2%)
$36.94M(+34.3%)
$107.12M(+31.5%)
Sep 2011
-
$27.50M(+36.0%)
$81.47M(-54.3%)
Jun 2011
-
$20.21M(-10.0%)
$178.37M(-14.7%)
Mar 2011
-
$22.47M(+99.0%)
$209.22M(-47.7%)
Dec 2010
$399.71M(+369.6%)
$11.29M(-90.9%)
$399.71M(-11.4%)
Sep 2010
-
$124.39M(+143.6%)
$451.19M(+33.2%)
Jun 2010
-
$51.06M(-76.0%)
$338.60M(+15.6%)
Mar 2010
-
$212.96M(+239.3%)
$292.92M(+244.2%)
Dec 2009
$85.11M(+621.6%)
$62.77M(+431.5%)
$85.11M(+505.2%)
Sep 2009
-
$11.81M(+119.5%)
$14.06M(+200.5%)
Jun 2009
-
$5.38M(+4.4%)
-$14.00M(-210.3%)
Mar 2009
-
$5.15M(+162.2%)
$12.70M(+22.1%)
Dec 2008
$11.79M(-86.4%)
-$8.28M(+49.1%)
$10.40M(-62.3%)
Sep 2008
-
-$16.25M(-150.7%)
$27.55M(-75.4%)
Jun 2008
-
$32.08M(+1024.7%)
$112.11M(+19.5%)
Mar 2008
-
$2.85M(-67.9%)
$93.83M(+8.4%)
Dec 2007
$86.53M(+8535.9%)
$8.88M(-87.0%)
$86.53M(-6.6%)
Sep 2007
-
$68.31M(+395.3%)
$92.64M(+273.3%)
Jun 2007
-
$13.79M(+410.3%)
$24.81M(+386.8%)
Mar 2007
-
-$4.44M(-129.7%)
$5.10M(+409.2%)
Dec 2006
$1.00M(-52.5%)
$14.98M(+2988.7%)
$1.00M(+107.2%)
Sep 2006
-
$485.00K(+108.2%)
-$13.98M(+3.4%)
Jun 2006
-
-$5.92M(+30.6%)
-$14.46M(-69.4%)
Mar 2006
-
-$8.54M(-1058.5%)
-$8.54M(-537.7%)
Dec 2005
$2.11M(+118.9%)
-
-
Sep 2004
-
$891.00K(+47.0%)
$1.95M(+181.4%)
Jun 2004
-
$606.00K(-88.8%)
-$2.40M(+53.0%)
Mar 2004
-
$5.42M(+209.1%)
-$5.10M(+62.3%)
Dec 2003
-$11.20M(+46.1%)
-$4.97M(-43.8%)
-$13.55M(-0.1%)
Sep 2003
-
-$3.46M(-64.6%)
-$13.53M(+8.9%)
Jun 2003
-
-$2.10M(+30.6%)
-$14.85M(+19.7%)
Mar 2003
-
-$3.02M(+38.9%)
-$18.49M(+10.9%)
Dec 2002
-$20.76M(+18.6%)
-$4.95M(-3.7%)
-$20.76M(+8.8%)
Sep 2002
-
-$4.78M(+16.8%)
-$22.75M(+7.9%)
Jun 2002
-
-$5.74M(-8.5%)
-$24.70M(+2.1%)
Mar 2002
-
-$5.29M(+23.9%)
-$25.23M(+1.0%)
Dec 2001
-$25.49M(-17.2%)
-$6.95M(-3.3%)
-$25.49M(-4.1%)
Sep 2001
-
-$6.72M(-7.2%)
-$24.48M(-2.8%)
Jun 2001
-
-$6.27M(-13.0%)
-$23.82M(-4.1%)
Mar 2001
-
-$5.55M(+6.5%)
-$22.89M(-5.2%)
Dec 2000
-$21.75M(-172.0%)
-$5.93M(+2.0%)
-$21.75M(-37.5%)
Sep 2000
-
-$6.06M(-13.4%)
-$15.82M(-60.2%)
Jun 2000
-
-$5.34M(-21.0%)
-$9.88M(-87.8%)
Mar 2000
-
-$4.42M(-3673.5%)
-$5.26M(-75.7%)
Dec 1999
-$8.00M(-58.5%)
-
-
Sep 1999
-
-$117.00K(+83.9%)
-$2.99M(+21.5%)
Jun 1999
-
-$727.00K(+8.8%)
-$3.81M(+14.8%)
Mar 1999
-
-$797.00K(+41.1%)
-$4.47M(+11.4%)
Dec 1998
-$5.05M
-$1.35M(-44.7%)
-$5.05M(-36.6%)
Sep 1998
-
-$935.00K(+32.6%)
-$3.69M(-33.9%)
Jun 1998
-
-$1.39M(-1.2%)
-$2.76M(-101.2%)
Mar 1998
-
-$1.37M
-$1.37M

FAQ

  • What is Amneal Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Amneal Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Amneal Pharmaceuticals, Inc.?
  • What is Amneal Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Amneal Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of AMRX is $353.29M

What is the all-time high annual operating profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high annual operating income is $399.71M

What is Amneal Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, AMRX annual operating income has changed by +$90.25M (+34.31%)

What is Amneal Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of AMRX is $114.02M

What is the all-time high quarterly operating profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high quarterly operating income is $212.96M

What is Amneal Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, AMRX quarterly operating income has changed by +$16.59M (+17.03%)

What is Amneal Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of AMRX is $381.28M

What is the all-time high TTM operating profit for Amneal Pharmaceuticals, Inc.?

Amneal Pharmaceuticals, Inc. all-time high TTM operating income is $451.19M

What is Amneal Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, AMRX TTM operating income has changed by +$48.69M (+14.64%)
On this page